1,i1¨3j]ƒÀ]D]glucan,435,519,566 A,abdominal pain,64 A,Absidia corymbifera,984 A,acute respiratory distress syndromeiARDSj,929 A,adenosine deaminaseiADAj,916 A,adenovirus,699 A,albendazole,442 A,alveolar hydatidosis,320 A,amantadine,846 A,amoeba,923 A,ampicillin]resistant Haemophilus influenzae,835 A,aneurysm,1016 A,anorexia nervosa,70 A,antagonism,290 A,antibiotic cycling,241 A,antibiotic susceptibility,253,835,943 A,antibody,967 A,antimicrobial activity,46 A,antimicrobial agent,482 A,arbekacin,305 A,Ascaris suum,1036 A,Aspergillus galactomannan,566 A,automated blood culture system,959 A,azithromycin,490 B,bacteremia,1026 B,bacterial meningitis,253,604,879 B,bacterial translocation,283 B,bactericidal activity,22 B,Bartonella henselae,270,574 B,ƒÀ]lactam,290,717,873 B,ƒÀ]lactamase]negative ampicillin]resistant Haemophilus influenzaeiBLNARj,604,891,943 B,ƒÀ]lactamase]nonproducing,835 B,blood culture,46 B,Bordetella pertussis,420 B,bronchiolitis obliterans organizing pneumonia,327 C,Campylobacter fetus,70 C,Candida standard ƒÀ]glucaniCSBGj,519 C,capsular polysaccharide antibody,451 C,cat scratch disease,574 C,ceftriaxone,604 C,ceramic,22 C,chickenpox,398 C,child,18,253,262,451,482,490,496,879,943,1031 C,China,699 C,Chlamydia pneumoniae,108 C,clindamycin,490 C,clinical isolate,83 C,clinical manifestation,470 C,clinical symptoms,681 C,Clostridium difficile,312,1026 C,Clostridium perfringens,32 C,CMY]2 gene,989 C,coagulase]negative Staphylococcus spp.,46 C,coccidioidomycosis,514 C,community]acquired infection,853 C,community]acquired pneumonia,108 C,comparative study,54 C,copper ions,138 C,coronavirus,991 C,Corynebacterium propinquum,277 C,cost]effectiveness,967 C,cryptococcosis,327,910 C,Cryptosporidium parvum,138 C,culture media,54 C,cutaneous infection,389 D,day nursery,482 D,delayed entry,959 D,dental treatment,554 D,diarrhea,32,312,1000 D,disinfection,90,138 D,disseminated intravascular coagulationiDICj,929 D,dissemination varicella zoster virus,64 D,distribution,710 D,DNA gyrase,428 D,drug resistance,305,428,873,1006 D,drug susceptibility,420,482 E,eaeA,975 E,elderly,995 E,empiric therapy,241 E,enterohemolysin,975 E,enterotoxin,32 E,environment]derived strain,83 E,enzyme immunoassay,597 E,eosinophilia,514 E,eosinophilic pneumonia,1036 E,epidemiology,120,411,470,853,879 E,erythromycin,829 E,Escherichia coli,1000 E,E test,420 E,extended]spectrum ƒÀ]lactamaseiESBLj,1 F,false negative,959 F,febrile neutropenia,241 F,ferret,274 F,floating microorganism,588 F,flow]through,865 F,fluoroquinolone,428 F,fts I,891 F,fungal infection,435,519 G,gastroenteritis,699 G,gastrointestinal infection,283 G,genotype,1 G,gnathostomiasis,442 G,Gram stain,277 G,group A streptococci,1006 G,gyrA,508 H,H1N2 subtype,476 H,Haemophilus influenzae,40,253,873,879,943 H,Haemophilus influenzae serotype b,451,835 H,hepatitis B virusiHBVj,554 H,hepatitis C virusiHCVj,554 H,herpes simplex virus type 1,59 H,hospital infection,295,305,967,995 H,hot spring,22,90,545,710 H,human metapneumovirus,129 H,humidity,411 I,immunoassay,865 I,immunoblotting,320 I,immunochromatography,597,935 I,immunocompromised patient,64 I,immunodeficiency,389 I,imported infectious disease,442 I,imported mycosis,514 I,indirect pathogen,823,829 I,induction,717 I,infant,404,496 I,influenza,99,120,262,597,681,935,995 I,influenza A virus,411 I,influenza B virus,411 I,influenza C virus,470 I,influenza vaccine,99 I,influenza virus,476,846,865 I,invasive streptococcal pyogenic infection,446 I,isolation,574 J,Japanese encephalitis,1020 K,Kaposifs varicelliform eruption,59 K,kidney transplant,984 L,Legionella,545,710,898 L,Legionella pneumophila,22,923 L,legionellosis,90,404 L,leptospirosis,288 L,linezolid,446 L,Listeria monocytogenes,1016 L,lobar pneumonia,910 L,lymphocytopenia,929 M,macrolide resistance,508 M,macrolide]resistant Streptococcus pneumoniae,490 M,macrophage,503 M,malnutrition,929 M,measles,398 M,mecA gene,54 M,meningitis,40,835 M,MIC,83,891 M,mice systemic infection,290 M,middle ear effusion,1031 M,miliary tuberculosis,929 M,minimum bactericidal concentrationiMBCj,40 M,minimum inhibitory concentrationiMICj,40 M,mixed infection,108 M,molecular epidemiology,835 M,MRSA,54,305,580,717,823,829,853,905,984 M,multidrug]resistance,989 M,multiplex PCR,699 M,mumps,398 M,Mycobacterium haemophilum,389 M,Mycobacterium tuberculosis,503,916 M,Mycoplasma pneumoniae,496,1031 N,nasopharyngeal carriage,18 N,National Notifiable Diseases Surveillance,248 N,neuraminidase inhibitor,995 N,non]specific reaction,435 N,nosocomial infection,32,312,853 N,nucleoprotein gene,815 N,nursing home,32,404 O,oseltamivir,262,846 O,otitis media,1031 O,outbreak,90,404 P,parC,508 P,pathogenesis,873 P,PCR,1031 P,penicillin]binding proteiniPBPj,508 P,peritonitis,916 P,pH,545 P,phage type,690 P,phospholipaseA2,503 P,photocatalyst coated lamp,588 P,phylogenic analysis,129,815 P,pneumonia,120,490,496 P,post]exposure prophylaxis,262 P,prognosis,253 P,prophylaxis,274 P,Proteus mirabilis,1 P,pseudomembranous enterocolitis,905 P,Pseudomonas aeruginosa,823,829 P,public health laboratory,248 P,pulsed]field gel electrophoresisiPFGEj,420,545,580,690,898,1006 P,pyrogenic exotoxin genes,1006 Q,questionnaire,99 R,rabies,274,815 R,radiological diagnosis,327 R,rapid diagnosis,120,597,681,846,865,935 R,re]emerging infectious disease,1020 R,receiver operating characteristic curve,566 R,resistance,717 R,resistant bacteria,241 R,respiratory tract infection,129,277,873 R,reverse transcription]polymerase chain reactioniRT]PCRj,129 R,rhabdomyolysis,59 R,risk factor,482 R,rotavirus,699 R,rubella,398,967 S,Salmonella Enteritidis,690 S,Salmonella Newport,989 S,sanitary maintenance,90 S,SARS,991 S,sealed rupture,1016 S,sepsis,70,283,295 S,serodiagnosis,320,435 S,serotype,83,1000 S,Serratia marcescens,295 S,shiga]toxin,1000 S,silver ions,22 S,smell molecule,588 S,specific pathogen]freeiSPFj,952 S,stability,991 S,standard precaution,554 S,streptococcal pyrogenic exotoxin,10 S,streptococcal toxic shock syndrome,10 S,Streptococcus pneumoniae,18,40,108,428,508,879 S,Streptococcus pyogenes,10 T,T serotype,1006 T,T]type,10 T,teicoplanin,46,580 T,thoracoabdominal aorta,1016 T,topoisomerase IV,428 T,Toxocara canis,114 T,travel,476 T,Tsutsugamushi disease,248 U,urinary antigen,18,404 V,vaccine,398,967 V,vanA,952 V,vancomycin,290,717,952,1026 V,vancomycin]resistant enterococciiVREj,952 V,verotoxin]producing Escherichia coli,975 V,Vibrio vulnificus,83 V,virulence,923 V,visceral larva migrans,1036 W,water]recirculating system,545 W,whirlpool,898 Z,zoonosis,114,1020